Tag

FDA Archives | SpecialtyCare

Samuel Weinstein, MD, MBA
By | Articles | January 6, 2017

Creating Certainty in an Uncertain Environment

From a healthcare perspective, the only thing we can be certain of in 2017 is that there will be uncertainty. For healthcare administrators, there is uncertainty around how to manage changes in provisions of the Affordable Care Act, Bundled Payments for Care Improvement (BPCI), and the Medicare Access and CHIP Reauthorization Act (MACRA). Restructuring Medicare and Medicaid could have a significant impact on planning, implementation, and payments for providers. But, regardless of the new format, healthcare providers like SpecialtyCare will always have an obligation—both to their patients and their customers—to improve value by providing high-quality care while containing costs.

Al Stammers
By | Articles | August 25, 2016

Tracking and Tackling the Nontuberculous Mycobacteria Outbreak

The source of nosocomial infections can be elusive. For investigators, infections stemming from slow-growing bacteria are particularly difficult to identify and combat when symptoms do not present for months, or sometimes even years, after exposure. Add to these challenges the severity of potentially deadly infections and a bacterial outbreak can have devastating consequences. Such is the case with nontuberculous mycobacteria (NTM).

Helene Petrovich
By | Articles | July 14, 2016

Best Practices in Team Collaboration and Infection Control

When I learned of a concern regarding Nontuberculous Mycobacteria (NTM) infections from use of LivaNova’s (previously Sorin) 3T heater-coolers and a change in their Instructions for Use (IFUs), I brought it to the attention of my OR Director at Memorial Medical Center. The situation has led to the development of best practices in team collaboration and infection control.